Holen Sie sich die Stockscreener-App
569.70
0.43%
2.4843
Regeneron Pharmaceuticals Inc Aktie (REGN) Neueste Nachrichten
Amundi Purchases 52,166 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Adage Capital Partners GP L.L.C. Has $58.82 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Royal Bank of Canada - MarketBeat
Regeneron Pharmaceuticals (REGN): Undervalued Innovator with Asymmetric Upside in 2025–2026 - AInvest
Regeneron Pharmaceuticals, Inc. $REGN Stock Position Lessened by Vident Advisory LLC - MarketBeat
Armistice Capital LLC Boosts Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Is a relief rally coming for Regeneron Pharmaceuticals Inc. holdersM&A Rumor & Safe Entry Zone Identification - Newser
Ieq Capital LLC Raises Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
What makes Regeneron Pharmaceuticals Inc. stock price move sharplyJuly 2025 Opening Moves & Scalable Portfolio Growth Ideas - Newser
Can Regeneron Pharmaceuticals Inc. expand its profit marginsJuly 2025 Rallies & Reliable Entry Point Trade Alerts - khodrobank.com
Sanofi’s amlitelimab hits phase III endpoints in atopic dermatitis - BioWorld MedTech
Landscape Capital Management L.L.C. Takes Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron’s Strategic Visibility in Upcoming Investor Conferences: A Glimpse into Innovation and Growth - AInvest
Leading Biotech Regeneron Announces New Time for Morgan Stanley Global Healthcare Conference - Stock Titan
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Canada Pension Plan Investment Board - MarketBeat
Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory - MSN
Regeneron at Wells Fargo Conference: Strategic Insights on Growth - Investing.com
Transcript : Regeneron Pharmaceuticals, Inc. Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-04-2025 09 - MarketScreener
Raymond James maintains Market Outperform rating on Regeneron stock - Investing.com
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Share Price Is Matching Sentiment Around Its Earnings - 富途牛牛
Measuring Regeneron Pharmaceuticals Inc.’s beta against major indicesJuly 2025 PostEarnings & AI Driven Stock Price Forecasts - Newser
Immuno-Oncology Q2 Earnings: Regeneron (NASDAQ:REGN) Simply the Best - Yahoo Finance
Is Regeneron Pharmaceuticals Inc. on track to beat earningsJuly 2025 Catalysts & Expert Curated Trade Setups - khodrobank.com
How high can Regeneron Pharmaceuticals Inc. stock goJuly 2025 Breakouts & AI Based Trade Execution Alerts - Newser
Magnetar Financial LLC Sells 96,608 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Momentum divergence signals in Regeneron Pharmaceuticals Inc. chart2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - Newser
Regeneron Tumbles 2.44% as 640M in Trading Volume Ranks 144th in Market Activity - AInvest
Lansforsakringar Fondforvaltning AB publ Sells 1,751 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals Inc. stock prediction for this weekJuly 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans - Newser
Regeneron Pharmaceuticals’ Strategic Position in the 2025 Biotech Landscape - AInvest
Regeneron at Cantor Global Healthcare Conference: Strategic Growth and Challenges - Investing.com
Can Regeneron Pharmaceuticals Inc. reach all time highs this yearQuarterly Earnings Summary & Reliable Entry Point Trade Alerts - khodrobank.com
Prostate Cancer Pipeline Analysi, 2025 by DelveInsight | Pfizer, Janssen Pharmaceutical, POINT Biopharma, Tavanta Therapeutics, Exelixis, Astellas Pharma Inc., Antev, ORCA Therapeutics, Regeneron Phar - Barchart.com
Sporadic Inclusion Body Myositis Market: Epidemiology, - openPR.com
The Manufacturers Life Insurance Company Purchases 41,826 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Key resistance and support levels for Regeneron Pharmaceuticals Inc.Market Trend Summary & Risk Controlled Daily Trade Plans - Newser
Regeneron Pharmaceuticals, Inc. $REGN Shares Purchased by GW Henssler & Associates Ltd. - MarketBeat
How Is Regeneron’s Stock Performance Compared to Other Pharma Stocks? - Yahoo Finance
What candlestick patterns are forming on Regeneron Pharmaceuticals Inc.Market Risk Analysis & Growth Focused Entry Reports - Newser
How to track smart money flows in Regeneron Pharmaceuticals Inc.July 2025 Sector Moves & AI Enhanced Trading Alerts - Newser
Will Regeneron Pharmaceuticals Inc. outperform the marketOptions Play & Low Volatility Stock Recommendations - Newser
Resistance Check: Can Regeneron Pharmaceuticals Inc. expand its profit marginsJuly 2025 Recap & Fast Moving Market Watchlists - khodrobank.com
How Is Regeneron’s Stock Performance Compared To Other Pharma Stocks? - Barchart.com
Regeneron Pharmaceuticals Inc. stock trend forecastJuly 2025 Movers & High Conviction Trade Alerts - Newser
Real time social sentiment graph for Regeneron Pharmaceuticals Inc. - Newser
OMERS ADMINISTRATION Corp Sells 639 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Te Ahumairangi Investment Management Ltd Makes New $896,000 Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Orion Investment Co Boosts Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
What are Regeneron Pharmaceuticals Inc.’s recent SEC filings showingJuly 2025 Pullbacks & Fast Gain Swing Trade Alerts - khodrobank.com
Intraday pattern recognizer results for Regeneron Pharmaceuticals Inc.July 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
Regeneron: Drug Pricing Woes Notwithstanding, Due For A Major Comeback (NASDAQ:REGN) - Seeking Alpha
Wellington Management Group LLP Sells 131,415 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Kestra Advisory Services LLC Reduces Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Evercore ISI Maintains a Buy on Regeneron Pharmaceuticals (REGN) With a $750 PT - MSN
Tema Etfs LLC Has $2.73 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
0.03%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):